Zydus Faces Xtandi Cancer Drug Patent Suit
Astellas Pharma and others have filed a patent infringement suit in New Jersey federal court seeking to block Zydus Pharmaceuticals from launching a generic version of prostate cancer treatment Xtandi, a...To view the full article, register now.
Already a subscriber? Click here to view full article